A protein called SLFN5 and how it acts in cancer
Original title: Structure, Function, and Role of Schlafen 5 in Cancer.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This is a summary of lab science, not a new result or a treatment.
The short version
A protein called SLFN5 seems to slow some cancers down but help others grow.
What was studied. This is a review paper. The authors gathered past lab research on a protein called Schlafen 5, or SLFN5, and looked at its shape, its jobs in cells, and how it acts in different cancers.
What they found. SLFN5 held back growth and spread in breast cancer and in one kind of kidney cancer. But in glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary, in prostate cancer that no longer responds to hormone treatment, and in colon cancer, it seemed to help the cancer move forward. Results in lung cancer did not agree with each other. The amount of SLFN5 in a tumor lined up with the tumor's stage, whether it had spread, and how long patients lived.
What this means, and what it doesn't
What it could mean: Nothing about your care changes because of this paper. One day, measuring SLFN5 might help doctors guess how a tumor will behave. For glioblastoma: A glioma that is given grade 4. Grade 4 is the highest grade there is. The tumor grows fast. Treatment usually starts soon after it is found. It often means surgery, and then radiation and chemotherapy. See the glossary, the work points to SLFN5 as something worth more study.
What it doesn't mean: This is not a new treatment, and it is not a cure. It is a summary of lab science, not a study that tested anything in people. There is no SLFN5 test or drug you can ask your doctor for. Much more work would be needed before any of this reaches the clinic.
Source: PubMed, October 29, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.